Transthyretin Amyloid Cardiomyopathy Clinical Trial
Official title:
Database of Transthyretin Amyloid Cardiomyopathy Cases in a Racially and Ethnically Diverse Population in the Bronx
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a commonly undiagnosed and potentially fatal disease. Contemporary studies on this condition often underrepresent the female gender and diverse patient populations. This registry retrospectively evaluated patients referred for 99mTc-pyrophosphate (PYP) Single Photon Emission Computed Tomography (SPECT) between 2014 and 2023 at Montefiore-Einstein in the Bronx. The patient population is racially and ethnically diverse and with a high proportion of females. Demographic, clinical (e.g. comorbidities), laboratory, echocardiographic, hospitalization, and mortality data were collected for each patient.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05896904 -
Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction
|
N/A | |
| Recruiting |
NCT06086353 -
A Study to Learn About Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in India
|
||
| Active, not recruiting |
NCT06321523 -
A Study to Learn About the Study Medicine Called Tafamidis 61mg in People Diagnosed With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
|
||
| Completed |
NCT05233163 -
SGLT2 Inhibitors in Transthyretin Amyloid Cardiomyopathy
|
Phase 4 | |
| Not yet recruiting |
NCT06101108 -
Early Diagnosis of Age-Linked CArdiac TransThyRetin Amyloidosis by Selective Screening in Spinal Stenosis Surgery
|
||
| Completed |
NCT04814186 -
A Study to Assess the Safety and Efficacy Of Tafamidis In Chinese Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
|
Phase 4 | |
| Recruiting |
NCT04899180 -
Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis
|
Early Phase 1 | |
| Recruiting |
NCT05259072 -
carDIo-ttranSSfOrm nucLEar Imaging Study
|
Phase 3 | |
| Recruiting |
NCT06183931 -
Study of ALXN2220 Versus Placebo in Adults With ATTR-CM
|
Phase 3 | |
| Recruiting |
NCT06328075 -
Artificial Intelligence to Assist the Echocardiographic Identification of Transthyretin Cardiac Amyloidosis
|
||
| Recruiting |
NCT06291805 -
Phenotyping and Characterization of wtATTR-CM (TRACE 1)
|
||
| Terminated |
NCT04424914 -
Global Prevalence of ATTR-CM in Participants With HFpEF
|
N/A | |
| Recruiting |
NCT06194825 -
EPIC-ATTR: A Study to Evaluate the Effect of Eplontersen on the Transthyretin Reduction and Long-term Safety in Chinese Subjects With Transthyretin Amyloid Cardiomyopathy
|
Phase 3 | |
| Recruiting |
NCT06372301 -
Dobutamine Stress Echocardiography in LF/LG Aortic Stenosis and Wild-type Transthyretin Amyloid Cardiomyopathy
|
N/A |